CD4 c.589A>G ;(p.I197V)

Variant ID: 12-6924140-A-G

NM_000616.4(CD4):c.589A>G;(p.I197V)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Significance of logistic regression scoring model based on natural killer cell-mediated cytotoxic pathway in the diagnosis of colon cancer.

Frontiers In Immunology
Ye, Zhen Z; Zhang, Huanhuan H; Liang, Jianwei J; Yi, Shuying S; Zhan, Xianquan X
Publication Date: 2023

Variant appearance in text: CD4: I197V
PubMed Link: 36742322
Variant Present in the following documents:
  • Table_7.xlsx, sheet 1
View BVdb publication page



COVID-19: comprehensive review on mutations and current vaccines.

Archives Of Microbiology
Hebbani, Ananda Vardhan AV; Pulakuntla, Swetha S; Pannuru, Padmavathi P; Aramgam, Sreelatha S; Badri, Kameswara Rao KR; Reddy, Vaddi Damodara VD
Publication Date: 2021-12-06

Variant appearance in text: CD4: I197V
PubMed Link: 34873656
Variant Present in the following documents:
  • Main text
View BVdb publication page



mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis.

Cell Reports
Triki, Mouna M; Rinaldi, Gianmarco G; Planque, Melanie M; Broekaert, Dorien D; Winkelkotte, Alina M AM; Maier, Carina R CR; Janaki Raman, Sudha S; Vandekeere, Anke A; Van Elsen, Joke J; Orth, Martin F MF; Grünewald, Thomas G P TGP; Schulze, Almut A; Fendt, Sarah-Maria SM
Publication Date: 2020-06-23

Variant appearance in text: CD4: I197V
PubMed Link: 32579932
Variant Present in the following documents:
  • mmc5.xlsx, sheet 3
View BVdb publication page